Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin for Pneumonia in Children
NCT05431023Unknown
- Sponsor
- Assiut University
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised trial of lactoferrin in pneumonia (2 arms), sponsored by Assiut University. Primary endpoint: Survival rate at 8 weeks. Status: unknown.
02
Drugs
lactoferrin
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT05431023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05431023.